Board of Directors

Clinical Trials Ontario has established a skills-based Board of Directors to guide the organization in this critical endeavour.

Raphael Hofstein


President and Chief Executive Officer
MaRS Innovation

Dr. Bradly Wouters

Vice-Chair and Secretary

Executive VP, Science & Research
University Health Network

Ed Dybka


President & General Manager
Ipsen Biopharmaceuticals Canada

Tina Ceroni

Clinical Trial Participant

Anne Ellis

Associate Professor and Chair, Division of Allergy & Immunology, Department of Medicine
Queen’s University

James Wilson

Brancorth Medical Inc.

Bev Heim-Myers

Canadian Coalition for Genetic Fairness

Mark Lundie

Director, Medical Affairs, Rare Diseases
Pfizer Canada Inc.

Clive Ward-Able

Former Executive Director, R&D